Epigallocatechin Gallate (EGCg) is the active ingredient of Matcha tea which allegedly has the ability to fight against the growth of cancer cells by inhibiting proliferation and inducing apoptosis. Though there have been extensive studies supporting the ability of EGCg to affect cancer cells, little has been done putting it in the context of the whole tea with other ingredients such as caffeine. Doing so allows for a more complete understanding of the tea’s effects on cancer growth, and not just EGCg. With the over 600,000 people expected to die from cancer within this next year, it is important to tests these claims to ensure that the fears of a deadly disease are not being used to take advantage of vulnerable people. The study of EGCg in conjunction with other tea ingredients will determine the drink’s potential as an anti-cancer method that can be adopted by those wishing to reduce their risk. While preliminary results utilizing isolated EGCg show promise in terms of the antioxidant’s ability to reduce growth, it is unclear whether or not this is physiologically relevant for average tea consumption. This study indicates that there are potentially significant limitations to the consideration of Matcha tea as a dietary supplement in cancer therapeutics.
Matcha Tea and Cross Roads between Cancer Prevention and Health Trends
- by Zach Johnson